Thought Leadership

New rules of engagement

New rules of engagement

Healthcare systems have changed forever as a result of COVID-19. How should pharma respond to the new rules of engagement?

Creating common endeavours

Creating common endeavours

Conclusio’s Johnny Skillicorn-Aston and James Roach consider the true meaning of patient-centricity in clinical trials

Deep impact

Deep impact

The NHS Long Term Plan and what the industry response should be

The Value Exchange

The Value Exchange

Simon Grime, of Wilmington Healthcare, explains the principles of exchanging value with customers to gain trust and consent

Continuity in a time of uncertainty

Continuity in a time of uncertainty

Tony Cordrey, vice president of European Strategic Operations Accord Healthcare, stresses the importance of ensuring consistency and continuity in medicines supply

Paving the way

Paving the way

Is Europe catching up (or pioneering the way) in digital therapeutics?

Once Upon A Time…

Once Upon A Time…

Emma Knott, associate director and head of Social Media at Publicis Resolute, says there’s power in pharma’s core narrative

Emotional pathways – the road less travelled

Emotional pathways – the road less travelled

Duncan Arbour, SVP Innovation, Syneos Health Communications Europe,  on the need for being faster to what really matters – finding the right  protocols for your patients